The following table summarizes the Company’s other current assets for each of the periods indicated:


	As of June 30, 2026		As of December 31, 2025
	(in thousands)
Collaboration and other receivables	$	45,016	$	104,117
Tax-related receivables and prepaids		13,487		15,604
Prepaid maintenance services		12,721		12,639
Prepaid clinical and pre-clinical expenses		7,694		7,976
Prepaid insurance		3,925		4,004
Prepaid commercial expenses		3,519		2,290
Interest receivable		3,487		1,656
Prepaid regulatory		1,183		2,335
Other		14,752		21,235
Total other current assets	$	105,784	$	171,856

The following table summarizes the Company’s other non-current assets for each of the periods indicated:


	As of June 30, 2026		As of December 31, 2025
	(in thousands)
Manufacturing-related deposits and prepaids	$	88,612	$	92,890
Intangible assets, net		30,609		28,949
Restricted cash and investments*		11,125		13,125
Strategic investments		6,348		9,520
Deferred tax asset		2,863		2,822
Prepaid maintenance services		2,422		3,058
Other		4,166		5,190
Total other non-current assets	$	146,145	$	155,554

* Restricted cash and investments for both periods relates to (i) letters of credit established under the Company’s various property leases that serve as security for potential future default of lease payments, (ii) a letter of credit established under a certain commercial supply agreement and (iii) collateralized cash for the Company’s credit cards. The restricted cash and investments are unavailable for withdrawal or use for general obligations.